logo

Iovance Biotherapeutics, Inc. (IOVA)



Trade IOVA now with
  Date
  Headline
10/11/2018 4:09:52 PM Iovance Biotherapeutics Announces Proposed Public Offering Of Common Stock
8/16/2018 8:04:17 AM Iovance Biotherapeutics Announces Trial Updates With Collaborators MD Anderson And Moffitt Cancer Center
6/7/2018 8:08:43 AM Iovance Biotherapeutics Says First Patient Dosed In Europe For Ongoing C-144-01 Phase 2 Trials In Metastatic Melanoma
6/6/2018 8:04:13 AM Advaxis Appoints Molly Henderson As EVP And CFO
4/10/2018 8:45:12 AM B. Riley FBR Upgrades Iovance Biotherapeutics, Inc. (IOVA) To Buy From Neutral With $22 Price Target
1/30/2018 6:41:48 AM In The Spotlight: Iovance
1/25/2018 7:48:42 AM Iovance Biotherapeutics Prices Underwritten Public Offering Of 13.04 Mln Shares At $11.50/shr
1/24/2018 4:03:09 PM Iovance Biotherapeutics Announces Public Offering Of Common Stock